\
&
Contact us
\
&
Contact us
Starts in 1 week from now
LocationStavanger, NO
The third edition of the AI, Data and Robotics Forum (ADRF25) brings together stakeholders to shape Europe’s digital future. Organized by ADRA with support from the EC and local partners, it focuses on responsible digital transformation and strategic autonomy.
The AI, Data and Robotics Forum (ADRF25) will bring together experts, innovators, and policymakers to discuss AI, data, and robotics topics. This event includes keynotes, panels, and sessions aimed at advancing the European agenda in these fields.
This annual event is organised by the AI, Data and Robotics Association (Adra) in cooperation with the European Commission, gathering leading experts and enthusiasts from the AI, Data, and Robotics community. Their mission is to shape the future of transformative technologies while promoting responsible innovation and societal impact.
This event is tailored for those involved in AI, Data, and Robotics who wish to engage with peers and contribute to shaping the future of these fields.
Visit the event website for registration and more details regarding the agenda and speakers: adrforum.eu
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
